A study of almost 1,000 pregnant women in Zimbabwe found that a daily dose of a commonly used, safe and inexpensive ...

Objectives To describe the outcomes of pregnancies in antiphospholipid antibody (aPL)-positive patients since the inception of the AntiPhospholipid Syndrome Alliance for Clinical Trials and ...

The prevalence of allergic, neurodevelopmental, and autoimmune conditions was similar between children born to anti-Ro antibody-positive mothers vs the general ... confirmed during the first trimester ...

The presentation highlighted that ocrelizumab may be safe during pregnancy ... than resuming high-efficacy treatment of anti-CD20 monoclonal antibodies, patients who want to conceive are switched ...

Anti-M antibodies with immunoglobulin (Ig) G components can lead to clinically significant hemolytic disease of the fetus and newborn (HDFN), necessitating careful monitoring and intervention during ...

Objective Adverse pregnancy outcomes are more common among women with ... Flow cytometry was used to measure CD4+ and CD8+ T cells, B cells, and NK cells. Positivity for anti-nuclear antibodies (ANA) ...

Updated classification criteria for antiphospholipid syndrome require patients display at least one positive antiphospholipid ... and/or IgG/IgM anti–2-glycoprotein I antibodies.

Blood from an Rh positive fetus can enter the bloodstream of the pregnant person and stimulate the production of anti-Rh antibodies ... affect your pregnancy. De Winter DP, Hulzebos C, Van 't Oever RM ...

In this study, the elimination of transfused platelets serves as a surrogate for assessing the ability of an anti-HPA-1a antibody to drive rapid elimination of HPA-1a positive fetal platelets from ...

Tyrosine kinase inhibitors (TKIs) in trastuzumab emtansine (T-DM1) resistant HER2-positive metastatic breast cancer: A real-world study. This is an ASCO Meeting Abstract from the 2022 ASCO Annual ...